Status of treatment of vascular dementia

Neuroepidemiology
H Lechner

Abstract

The therapeutic goal in treating vascular dementia has been based on its presumed association with cerebral arteriosclerosis. Therefore, it is necessary to control risk factors for arteriosclerosis. In this connection, application of platelet-aggregating substances has been used extensively. Promising results have also been observed by altering the hemorheologic profile because hemorheologically active substances may be able to ameliorate the course of vascular dementia. Further improvement could be achieved by application of the HELP system to enhance the effect of hemorheologically active drugs. Using the HELP system, LDL, cholesterol, triglycerides and fibrinogen can be lowered considerably and may result in clinical improvement or slowing of the progression of vascular dementia.

Citations

Jul 12, 2005·Current Treatment Options in Cardiovascular Medicine·Hee-Joon Bae, Dilip K Pandey
Jun 13, 2000·Alzheimer Disease and Associated Disorders·J C de la Torre
Mar 7, 2003·Alzheimer Disease and Associated Disorders·Michael C Sha, Christopher M Callahan
Feb 15, 2005·International Journal of Clinical Practice·A GuptaK Pansari
Dec 6, 2005·Cerebrovascular Diseases·Gustavo C Román
Jan 26, 2006·British Journal of Clinical Pharmacology·J A 'Chris' DelaneySamy Suissa
Mar 21, 2006·Atherosclerosis·Jeff Thompsen, Paul D Thompson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.